RDCA-DAP, Research & Drug Development Shortening the Timeline for Developing New Treatments – How the RDCA-DAP® Can Help
RDCA-DAP, Regulatory, Research & Drug Development Published October 21, 2020 How Can Patients and Advocates Help Accelerate Drug Development?
RDCA-DAP, Research & Drug Development Published October 21, 2020 How Does Data Sharing Improve the Understanding of Rare Diseases?
Advocacy, RDCA-DAP, Research & Drug Development Why is it important to your organization to be involved with RDCA-DAP®?
RDCA-DAP, Research & Drug Development Accelerating Rare Disease Drug Development: RDCA-DAP – Shortening the Timeline for Developing New Treatments for Rare Diseases
RDCA-DAP, Research & Drug Development Accelerating Rare Disease Drug Development: Rare Disease Challenges in Each Step of the Drug Development Process.
RDCA-DAP, Research & Drug Development Accelerating Rare Disease Drug Development: The Drug Development Process
Advocacy, RDCA-DAP, Research & Drug Development What You Need to Know About the Rare Disease Cures Accelerator-Data and Analytics Platform
Membership, RDCA-DAP, Research & Drug Development How Patient Nonprofits Can Help Accelerate Drug Development
RDCA-DAP, Research & Drug Development Published December 1, 2021 How Will RDCA-DAP® Support Patient Focused Drug Development?
RDCA-DAP, Research & Drug Development, Understanding Rare Disease What is Patient Focused Drug Development (PFDD)?
Diversity, Equity & Inclusion Published March 1, 2022 Diversity, Equity and Inclusion – Part 2 (Membership Inclusivity: Who’s Left Out? Recognizing Barriers and Building an Inclusive Community)